Don’t call it BioBots anymore: Allevi is the new name of the Pennovation-based startup, makers of a 3D printer for live tissue, that is now making a play for the software space in addition to its hardware offering.

The company, which moved its team of 10 to Pennovation in February, parted ways with cofounder Danny Cabrera, who left the startup in August and is working on a San Francisco-based project around genetic engineering.

Cofounder Ricky Solorzano is now the CEO of the company under its new banner. The Penn grad is leading the startup as it raises another round of capital, a follow-up to the $1.25 million the company took on in 2015 from DreamIt Ventures, 500 Startups and Ben Franklin Technology Partners.

READ FULL ARTICLE HERE